 | | | | HARARE (Reuters) - Zimbabwe will join other countries in banning imports of processed meat products from South Africa after a deadly listeria outbreak there, Zimbabwe's ministry of health said in a statement on Tuesday. | | |
| | | BUDAPEST (Reuters) - A man has died of the H1N1 flu virus in a hospital in Hungary, national news agency MTI said on Tuesday, quoting regional daily Eszak-Magyarorszag. | | |
| | | TEL AVIV (Reuters) - Israel's Medial EarlySign, whose machine-learning based technology is meant to help improve patient management, said on Tuesday it raised $30 million, bringing its total funding to $50 million. | | |
| | | JOHANNESBURG (Reuters) - South Africa said on Monday producers of cold meat products were to blame for delays in tracing the cause of the world's worst listeria outbreak, which has killed 180 people in the past year. | | |
| | | NEW YORK (Reuters) - Former drug company executive Martin Shkreli may have to give up a Picasso and a one-of-a-kind Wu-Tang Clan album, after a U.S. judge on Monday ordered him to forfeit $7.36 million following his conviction of defrauding investors. | | |
| | | WASHINGTON (Reuters) - Arkansas on Monday became the third U.S. state to require that Medicaid recipients work or participate in employment activities as a condition of receiving health insurance as the Trump administration continues to approve state requests that fundamentally change the 50-year-old program. | | |
| | | (Reuters Health) - U.S. states with the strongest firearm laws have fewer gun-related murders and fewer suicides than states that take a more permissive approach to regulating these weapons, a new study suggests. | | |
| | | (Reuters) - Drug developer Clearside Biomedical Inc said on Monday its treatment helped improve vision in patients with fluid buildup in the eye in a late-stage study, sending its shares surging 54.1 percent in premarket trading. | | |
| | | (Reuters Health) - Child abuse survivors may be less likely to die prematurely when they develop supportive relationships by middle age, a U.S. study suggests. | | |
| | | (Reuters) - Dermira Inc will discontinue development of its acne drug after the treatment failed to meet the main goals of two late-stage studies, the company said on Monday. | | |
|
| |
